Cargando…

Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial

BACKGROUND: 8‐Oxo‐2′‐deoxyguanosine (8‐oxo‐2′‐dG) is a biomarker of oxidative DNA damage that is associated with cardiovascular disease and premature mortality in the general population. Although oxidative stress has a proven role in cardiovascular complications in diabetes mellitus, evidence for a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Merlin C., Woodward, Mark, Li, Qiang, Pickering, Raelene, Tikellis, Christos, Poulter, Neil, Cooper, Mark E., Marre, Michel, Zoungas, Sophia, Chalmers, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064915/ https://www.ncbi.nlm.nih.gov/pubmed/29960985 http://dx.doi.org/10.1161/JAHA.117.008226

Ejemplares similares

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
por: Mohammedi, Kamel, et al.
Publicado: (2016)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2021)

Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus
por: Hillis, Graham S., et al.
Publicado: (2012)

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
por: van der Leeuw, Joep, et al.
Publicado: (2016)

The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
por: Nguyen, Tu N., et al.
Publicado: (2021)

The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
por: Blomster, Juuso I, et al.
Publicado: (2016)

Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial
por: Woodward, Mark, et al.
Publicado: (2011)

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
por: Zoungas, Sophia, et al.
Publicado: (2009)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
por: Welsh, Paul, et al.
Publicado: (2018)

Associations between body mass index and the risk of renal events in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2018)

Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice
por: Watson, Anna M.D., et al.
Publicado: (2012)

Oxidative Stress and Inflammation in Cardiovascular Diseases
por: Pickering, Raelene J.
Publicado: (2021)

Circulating Soluble ACE2 Plays an Independent Role to Protect against Vascular Damage in Diabetic Mice
por: Tikellis, Chris, et al.
Publicado: (2022)

Short-Term Treatment with Diminazene Aceturate Ameliorates the Reduction in Kidney ACE2 Activity in Rats with Subtotal Nephrectomy
por: Velkoska, Elena, et al.
Publicado: (2015)

Urinary 8-Hydroxy-2′-Deoxyguanosine Levels and Cardiovascular Disease Incidence in Japan
por: Nagao, Masanori, et al.
Publicado: (2020)

Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study
por: Harris, Katie, et al.
Publicado: (2020)

Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial
por: Hata, Jun, et al.
Publicado: (2013)

Amylin in the Periphery
por: Wookey, Peter J., et al.
Publicado: (2003)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

ACE2, a new regulator of the renin–angiotensin system
por: Burrell, Louise M., et al.
Publicado: (2004)

Mitochondrial 8-hydroxy-2′-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus
por: Wang, Xue-bin, et al.
Publicado: (2020)

Elevated Plasma Level of 8-Hydroxy-2′-deoxyguanosine Is Associated with Primary Open-Angle Glaucoma
por: Kondkar, Altaf A., et al.
Publicado: (2020)

The Concentration of 8-Hydroxy-2′-Deoxyguanosine in Plasma During the Menstrual Cycle in Young Japanese Women
por: Yama, Kaori, et al.
Publicado: (2022)

8-Oxo-7,8-Dihydro-2′-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2′-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development
por: Urbaniak, Sandra K., et al.
Publicado: (2020)

Characterization of the Deoxyguanosine–Lysine Cross-Link of Methylglyoxal
por: Petrova, Katya V., et al.
Publicado: (2014)

8-Oxo-7,8-dihydro-2'-deoxyguanosine Forms a Relatively Unstable Tetrameric Structure Compared with 2'-Deoxyguanosine
por: Iwahashi, Hideo
Publicado: (2009)

Increased Plasma Levels of 8-Hydroxy-2′-deoxyguanosine (8-OHdG) in Patients with Pseudoexfoliation Glaucoma
por: Kondkar, Altaf A., et al.
Publicado: (2019)

THE INFLUENCE OF PERIODONTAL DISEASE TREATMENT ON 8-HYDROXY-DEOXYGUANOSINE CONCENTRATIONS IN SALIVA AND PLASMA OF CHRONIC PERIODONTITIS PATIENTS
por: Veljović, Tanja, et al.
Publicado: (2020)

8-Hydroxy-2-Deoxyguanosine Levels and Cardiovascular Disease: A Systematic Review and Meta-Analysis of the Literature
por: Di Minno, Alessandro, et al.
Publicado: (2016)

Plasma 25(OH)D Concentrations and Gestational Diabetes Mellitus among Pregnant Women in Taiwan
por: Pham, Thu T. M., et al.
Publicado: (2021)

Oh! Pascal! /
por: Cooper, Doug
Publicado: (1985)

Biotinylation of Deoxyguanosine at the Abasic Site in Double-Stranded Oligodeoxynucleotides
por: Wu, Chun
Publicado: (2016)

Alpha-Deoxyguanosine to Reshape the Alpha-Thrombin Binding Aptamer
por: Kolganova, Natalia A., et al.
Publicado: (2023)

Serum Cortisol, 25 (OH)D, and Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus
por: Jin, Yuxi, et al.
Publicado: (2022)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
por: van Steen, Sigrid C., et al.
Publicado: (2018)

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
por: Oshima, Megumi, et al.
Publicado: (2019)

Candesartan Attenuates Diabetic Retinal Vascular Pathology by Restoring Glyoxalase-I Function
por: Miller, Antonia G., et al.
Publicado: (2010)

Structure and dynamics of the deoxyguanosine-sensing riboswitch studied by NMR-spectroscopy
por: Wacker, Anna, et al.
Publicado: (2011)

Structural principles of nucleoside selectivity in a 2′-deoxyguanosine riboswitch
por: Pikovskaya, Olga, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ijr9t2h4vbm856tpt5ktitfhvf